Andere Sprachen Aquestive Therapeutics, Inc.

Aktien

A2JQ4G

US03843E1047

AQST

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.04.2024			% 5 Tage	% 1. Jan.
3.92 ^USD	+1.82%		-3.69%	+94.06%

12.04.	Aquestive Therapeutics, Inc. präsentiert Crossover-Studiendaten für Libervant (Diazepam) Buccal Film auf der 76. Jahrestagung der American Academy of Neurology	CI
11.04.	AQUESTIVE THERAPEUTICS, INC. : Piper Sandler behält die Bewertung Kaufen bei	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aquestive Therapeutics to Present Crossover Study Data for Libervant Buccal Film at 76th Annual Meeting of the American Academy of Neurology	15.04.
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology	12.04.
Aquestive Therapeutics, Inc. to Present Crossover Study Data for Libervant Buccal Film At 76th Annual Meeting of the American Academy of Neurology	12.04.
Aquestive Therapeutics Files $250 Million Mixed Shelf	03.04.
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01.04.
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01.04.
Aquestive Therapeutics, Inc. Appoints Abigail Jenkins to Board of Directors, Effective April 1, 2024	01.04.
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock	25.03.
Top Midday Decliners	20.03.
Sector Update: Health Care Stocks Steady Premarket Wednesday	20.03.
Wall Street Set to Open Flat as Investors Look Toward Fed Decision; Oil Prices Drop Sharply	20.03.
Top Premarket Decliners	20.03.
Aquestive Therapeutics Prices $75 Million Common Stock Offering; Shares Slump Premarket	20.03.
Aquestive Therapeutics Prices $75 Million Common Stock Offering	20.03.
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock	20.03.
Aquestive Therapeutics Proposes Public Stock Offering -- Shares Drop	19.03.
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock	19.03.
Sector Update: Health Care Stocks Edge Higher Premarket Friday	15.03.
Aquestive Therapeutics' Anaphylm Demonstrates Faster Maximum Concentration Reach in Phase 3 Trial	14.03.
Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting	14.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aquestive Therapeutics, Inc.

Aktien

A2JQ4G

US03843E1047

AQST

Andere Sprachen

Filter